Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Adakveo, crizanlizumab, Anemia, Sickle Cell, Date of authorisation: 28/10/2020, Revision: 4, Status: Authorised
TO: